NXI Therapeutics
2 known investors
Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.
Investors · 2
Frequently asked questions
- What does NXI Therapeutics do?
- Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.
- Who are NXI Therapeutics's investors?
- NXI Therapeutics's investors include BioMedPartners, Kickfund.